6 days ago5 minBausch + Lomb and Novaliq Announce FDA Approval of MIEBO for the Treatment of Dry Eye Disease
May 193 minBoehringer Ingelheim Begins Clinical Development of First-In-Class Treatment for Fibrotic Diseases
Apr 212 minAscendis Pharma’s Initial Dose Escalation Results Accepted for Online Publication at ASCO 2023
Mar 311 minApogenix’ partner CANbridge announces 67 % five-year overall survival rate compared to 8.2 %
Mar 313 minAION Labs, In Continued Partnership with BioMed X, Launches First 2023 Global Call for Applications
Mar 243 minState of Baden-Württemberg agrees on close association model for the two university hospitals